MarketResearchReports.com: Coronary Stents Market in India 2013, New Report Launched

Coronary stents Market in India 2013 report states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.

Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower.  It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.

Since the medical equipment and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 has come as a body blow to manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower prices in the open market as well. The Drugs and Cosmetics (Amendment) Bill, 2013 was presented before the Parliament of India in August 2013 and if the Bill is passed, it will provide the growing medical devices sector an impetus in the form of a much needed regulatory mechanism and will benefit the coronary stents market as well.

Spanning over 134 pages and 30 figures, “Coronary Stents Market in India 2013” report provide operator strategy, business development and/or corporate development team.

In addition to covering the Overview of Macroeconomic Indicators, Introduction, Market Overview, Drivers & Challenges, Government Involvement, Competitive Landscape, Buyer Details, Recent Developments, Strategic Recommendation, Appendix. The report cover 1 Public Companies & 9 Private Companies- Opto Circuits (India) Ltd., Abbott Healthcare Pvt. Ltd., B. Braun Medical (India) Pvt. Ltd., Boston Scientific India Pvt. Ltd., India Medtronic Pvt. Ltd.,MIV, Meril Life Sciences Pvt. Ltd., Relisys Medical Devices Ltd., Sahajanand Medical Technologies Pvt. Ltd., Vascular Concepts Ltd.

For more information visit : http://www.marketresearchreports.com/netscribes-india-pvt-ltd/coronary-stents-market-india-2013

Find all Pharma and Healthcare reports under a single page

MarketResearchReports.com: PharmaPoint: Meningococcal Vaccines - Current and Future Players, New Report Launched

Publisher has released its pharma report, “PharmaPoint: Meningococcal Vaccines - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Meningococcal Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Meningococcal Vaccines market. The report provides insight into the competitive Meningococcal Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

• Investigation of current and future market competition for Meningococcal Vaccines
• Competitor assessment
• Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
• Strategic assessment of the Meningococcal Vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

• Gain a high level view of the trends shaping and driving the Meningococcal Vaccines Market
• Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
• Create an effective counter-strategy to gain a competitive advantage against those currently in the market
• What’s the next big thing in the global Meningococcal Vaccines market landscape? Identify, understand and capitalize

Spanning over 70 pages, 17 tables and 2 figures, “PharmaPoint: Meningococcal Vaccines - Current and Future Players” report includes Market Outlook, Current and Future Players, Trends in Corporate Strategy, Company Profiles. . The report cover 6 companies -  Sanofi, Novartis, GlaxoSmithKline, Baxter, Nuron Biotech, Pfizer.

For more information visit: http://www.marketresearchreports.com/globaldata/pharmapoint-meningococcal-vaccines-current-and-future-players

Find all Medical Diseases reports under a single page

MarketResearchReports.com: MediPoint: Hernia Repair - Current and Future Players, New Report Launched

Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation biologic and composite meshes in developed countries and adoption of laparoscopic techniques worldwide, will drive hernia repair market growth in the US, Europe and Asia Pacific. Saturated with numerous players and a library of different products, the fiercely-competitive hernia mesh industry has experienced notable improvements recently in device quality and affordability, as companies strive for increased physician adoption in established markets and strategize entry into new regions.

The report identifies and analyzes the key companies shaping and driving the global hernia repair market. The report provides insight into the competitive hernia repair landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading surgeons, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

• Investigation of current and future market competition for hernia repair
• Competitor assessment including device approval analysis.
• Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
• Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
• Direct quotes from Key Opinion Leaders (KOL) as well as surgeons using hernia repair devices in clinical practice.

Reasons to buy

• Gain a high level view of the trends shaping and driving the hernia repair market for coronary applications and peripheral applications in the lower extremity.
• Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
• Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
• Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
• Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

Spanning over 166 pages, 92 tables and 60 figures, “MediPoint: Hernia Repair - Current and Future Players” report includes Competitive Assessment, Pipeline Products, Current and Future Players. The report cover 15 companies -  Abiss Analytic Biosurgical Solutions, AMI: Agency for Medical Innovation, Angiologica, Aspide Medical, Assut Europe, Atrium Medical, B. Braun Surgical, Cook Medical, Cousin Biotech, Covidien, C.R. Bard, Ethicon, FEG Textiltechnik mbH, Proxy Biomedical, TEI Bioscienc.

For more information visit: http://www.marketresearchreports.com/globaldata/medipoint-hernia-repair-current-and-future-players

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: U.S. Markets for Anesthesia, Respiratory and Sleep Management Devices, New Report Launched

The U.S. market for anesthesia, respiratory and sleep management devices is showing signs of sustained recovery, with particularly strong growth in sleep and oxygen therapy markets.

This market includes anesthesia delivery units, anesthesia monitors, anesthesia information management systems, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy equipment, sleep therapy devices and sleep diagnostic devices. Dominated in value by the market for sleep therapy devices, the U.S. market for anesthesia, respiratory and sleep management devices is expected to accelerate and maintain strong growth over the forecast period.

Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment & Country
• Trend Analysis by Segment & Country
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Markets Included:

• Anesthesia Delivery Units
• Anesthesia Monitors
• Anesthesia Information Management Systems
• Anesthesia Disposables
• Ventilators
• Nebulizers
• Respiratory Disposables
• Oxygen Therapy
• Therapeutic Obstructive Sleep Apnea Devices
• Sleep Diagnostic Devices

Sub-Segments Included:

• Hospital OR ADU (High complexity and low complexity)
• Other hospital suite (MRI, Obstetrics and Other) ADU
• Hospital Preoperative Anesthesia Monitors
• Hospital Operating Room Anesthesia Monitors
• Hospital Post-Anesthesia Care Unit Anesthesia Monitors
• Hospital Obstetric Anesthesia Monitors
• ASC Preoperative Anesthesia Monitors
• ASC Operating Room Anesthesia Monitors
• ASC Post-Anesthesia Care Unit Anesthesia Monitors
• Hospital AIMS
• ASC AIMS
• Anesthesia Circuit Market
• Anesthesia Mask Market
• Endotracheal Tube Market Laryngeal Mask Market (Disposable and Reusable)
• Acute-Care Ventilators
• Sub-Acute Ventilators
• Home-Care Ventilators
• Neo-Natal Ventilators
• Non-Invasive Ventilators
• Stationary Compressor/Jet Nebulizer Market
• Portable Compressor/Jet Nebulizer Market
• Ultrasonic Nebulizer Market
• Vibrating Mesh Market
• Oxygen Cannula Market
• Oxygen Mask Market
• Tracheostomy Tube Market
• Resuscitator Market
• Stationary Oxygen Concentrator Market (Standard and High-Flow)
• Ambulatory Oxygen Concentrator Market (Transportable and Portable)
• Transfilling Device Market
• Aluminum Medical Oxygen Cylinder Market (Ambulatory and Back-up)
• Medical Oxygen Regulator Home Care Market
• Oxygen Conserver Market (Pneumatic and Electronic)
• Continuous Positive Airway Pressure (CPAP) Device Market
• Auto-Titrating Positive Airway Pressure (APAP) Device Market
• Bi-Level Positive Airway Pressure Device Market
• Sleep Therapy Interface Market
• Nasal Mask Market
• Full-Face Mask Market
• Nasal Pillow/Alternative Interface Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 242 pages, “Chinese Market for Neurological Devices” report includes U.S. Anesthesia, Respiratory and Sleep Management Device Market, Anesthesia Delivery Unit Market, Anesthesia Monitor Market, Anesthesia Information Management System Market, Anesthesia Disposables Market, Ventilator Market, Nebulizer Market, Respiratory Disposables Market, Oxygen Therapy Market, Therapeutic Obstructive Sleep Apnea Device Market, Sleep Diagnostic Device Market.

For more information visit: http://www.marketresearchreports.com/idata-research/us-markets-anesthesia-respiratory-and-sleep-management-devices

Find all Medical devices reports under a single page

MarketResearchReports.com: Chinese Market for Neurological Devices, New Report Launched

The Chinese market for neurological devices includes fixed pressure CSF shunts, adjustable pressure CSF shunts, bare platinum detachable coils, coated detachable coils, liquid embolics, neurovascular catheters, neurovascular stents, neurovascular guide wires, deep brain stimulators (DBS), spinal cord stimulators (SCS), sacral nerve stimulators (SNS), intrathecal pumps, frame-based stereotactic systems, frameless stereotactic systems and aneurysm clips.

Market growth will be driven by the continued acceptance of aneurysm treatment procedures, arteriovenous malformation (AVM) treatment procedures and frameless stereotactic treatment for cranial tumors.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for China.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment
• Trend Analysis by Segment
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Detachable Coil Market
• Liquid Embolics Market
• Neurovascular Stent Market
• Neurovascular Catheter Market
• Neurovascular Guidewire Market
• Neuromodulator Market
• Stereotactic System Market
• Aneurysm Clip Market
• Cerebrospinal Fluid Shunt Market
• Emerging Market: Ultrasonic Aspirator Market
• Emerging Market: Transcranial Magnetic Stimulator Market
• Emerging Market: Intracranial Pressure Monitoring Device Market

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Spanning over 242 pages, “Chinese Market for Neurological Devices” report includes Chinese Neurological Device Market, Neurological Procedures, Cerebrospinal Fluid Shunt Market, Detachable Coil Market, Liquid Embolics Market, Neurovascular Stent Market, Neurovascular Catheter Market, Neurovascular Guidewire Market, Neuromodulation Market, Stereotactic System Market, Aneurysm Clip Market, Emerging Market: Ultrasonic Aspirator Market, Emerging Market: Transcranial Magnetic Stimulator Market, Emerging Market: Intracranial Pressure Monitoring Device Market, Appendix: Neuroendoscope Market.

For more information visit: http://www.marketresearchreports.com/idata-research/chinese-market-neurological-devices

Find all Pharmaceuticals and Healthcare reports under a single page

MarketResearchReports.com: MediPoint: Trauma Fixation - EU Analysis and Market Forecasts, New Report Launched

Traumatic injury patients that come into the Emergency Room (ER) experience orthopedic injury in the form of fractures 60% to 65% of the time, based on publisher conversations with key opinion leaders. Of this population, 45%–50% are operable and require fracture repair techniques in the form of external or internal fixation. As the global population continues to grow in the emerging markets, with overcrowding and economic growth, some of the drivers for trauma fixation include motor vehicle accidents and aging. Publisher analysis shows that while the orthopedics implant market is mature, where products have become commodities, trauma fixation is one that has room for more technological development and adoption.

The EU market is an unsure market with regards to high growth in trauma fixation. There is a strong dependence on reimbursement which can vary between nations. Moving forward publisher believes that the most growth will continue to be IM nails, due to the minimally invasive approach they have compared with other systems.

Scope

• An overview of bone trauma, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
• Annualized EU trauma fixation market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
• Investigation of current and future market competition for trauma fixation
• Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
• Competitor assessment including device approval analysis and device sales forecasts.
• Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
• Analysis of unmet needs within the market and opportunities for future players.
• Technology trends evaluation to assess strength of pipeline.
• An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
• Company profiles including business description, financial overview and SWOT analysis.
• Coverage of key market players.
• Strategic assessment of the trauma fixation sector through market impact analysis, future market scenario and company analysis.
• Direct quotes from Key Opinion Leaders (KOL) as well as Orthopedic Surgeons.

Reasons to buy

• Understand the trends shaping and driving the EU trauma fixation Market.
• Realize device preferences of physicians who have performed the tests already.
• Access market sizing, forecasts and quantified growth opportunities in the EU trauma fixation market through 2018.
• Quantify candidate patient populations to better design product pricing & launch plans.
• Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
• Perform benchmarking analysis of growth opportunities against currently marketed products.
• Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
• Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
• Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
• Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
• What’s the next big thing in EU trauma fixation market landscape? Identify, understand and capitalize.

Spanning over 198 pages, 104 tables and 33 figures, “MediPoint: Trauma Fixation - EU Analysis and Market Forecasts” report includes Disease Overview, Industry Overview, Competitive Assessment, Unmet Needs, Pipeline Products, Clinical Trials to Watch, Current and Future Players, Market Outlook. The report cover 13 Companies- Acumed, Biomet, DePuy Synthes International, Integra LifeSciences, Orthofix, OsteoMed, Small Bone Innovations, Inc., Smith & Nephew, Stryker, Tornier, Trimed Inc., Wright Medical, Zimmer.

For more information visit: http://www.marketresearchreports.com/globaldata/medipoint-trauma-fixation-eu-analysis-and-market-forecasts

MarketResearchReports.com: MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecast, New Report Launched

MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in the US. The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics.

The DEB market in the US was assessed to identify the unmet needs in the market, understand the regulatory challenges DEB manufacturers will encounter in the US, identify the challenges to adoption in clinical practice and evaluate future adoption of DEB for select coronary and peripheral indications. The US sales expectations are discussed through careful analysis of adoption patterns of using DEB.

Clients can use this report to better understand the scope of this technology and for strategic planning to explore opportunities in this dynamic market. The report provides insights into the competitive landscape, the marketed and pipeline DEB products, the current and emerging players and comparative market analysis of different types of interventional techniques used to treat coronary and peripheral artery disease. This report is built using data and information sourced from secondary sources and primary research interviews and survey with leading Interventional Cardiologists and Interventional Radiologists, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

• An overview of coronary artery disease and peripheral artery disease in the lower extremity, which includes epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
• Annualized total drug-eluting balloon market revenue by type of disease, annual cost of disease and drug-eluting balloons adoption pattern and procedure data in the US from 2010-2012 and forecast for seven years to 2019.
• Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access and implications of the drug-eluting balloon market.
• Pipeline analysis: comprehensive data split across different stages of development, emerging trends and DEB designs in development, including investigation of DEB coating technology, antiproliferative agent used, balloon and catheter design and durability.
• Analysis of the current and future market competition in the US drug-eluting balloon market. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy-

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends that will shape and drive the DEB market in the US.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the US DEB market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the US DEB market by disease and indication from 2010-2019.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Spanning over 377 pages, 142 tables and 41 figures, “MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts” report includes Disease Overview, Competitive Assessment, Unmet Needs, Pipeline Products, Clinical Trial Analysis, Industry Overview, Current and Future Players, Market Drivers, Opportunities, Barriers and Substitutes, Drug-Eluting Balloon Market Analysis, Country Outlooks & Forecasts. For more information visit: http://www.marketresearchreports.com/globaldata/medipoint-drug-eluting-balloons-us-analysis-and-market-forecasts

The report cover 17 companies - Aachen Resonance, AnGes MG, AngioScore, AVIDAL Vascular, B. Braun, Biosensors International, Biotronik, Blue Medical, Boston Scientific Corporation, Caliber Therapeutics, Cardionovum, Concept Medical Research, Cook Medical, Covidien, C.R. Bard, DSM Biomedical, Elixir Med.

Find all Pharmaceuticals and Healthcare reports under a single page